Of marsupials and men: “Backdoor” dihydrotestosterone synthesis in male sexual differentiation

[1]  W. Miller,et al.  Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. , 2011, American journal of human genetics.

[2]  W. Miller,et al.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.

[3]  A. Biason-Lauber.  Control of sex development. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[4]  W. Miller,et al.  Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. , 2008, The Journal of clinical endocrinology and metabolism.

[5]  T. Penning,et al.  Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens. , 2006, Biochemistry.

[6]  David I. Wilson,et al.  In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. , 2006, The Journal of clinical investigation.

[7]  M. Baser.  The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene , 2006, Human mutation.

[8]  Pierre Legrand,et al.  Comparison of crystal structures of human type 3 3α‐hydroxysteroid dehydrogenase reveals an “induced‐fit” mechanism and a conserved basic motif involved in the binding of androgen , 2005, Protein science : a publication of the Protein Society.

[9]  R. Auchus.  The backdoor pathway to dihydrotestosterone , 2004, Trends in Endocrinology & Metabolism.

[10]  J. Richardson,et al.  Steroid 5α-reductase 1 promotes 5α-androstane-3α,17β-diol synthesis in immature mouse testes by two pathways , 2004, Molecular and Cellular Endocrinology.

[11]  T. Penning,et al.  Structure–function of human 3α-hydroxysteroid dehydrogenases: genes and proteins , 2004, Molecular and Cellular Endocrinology.

[12]  P. Donahoe,et al.  Sex determination and differentiation. , 2004, The New England journal of medicine.

[13]  T. Penning,et al.  Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. , 2003, The Journal of biological chemistry.

[14]  R. Auchus,et al.  5α-reduced C21 steroids are substrates for human cytochrome P450c17 , 2003 .

[15]  W. Miller,et al.  The 17, 20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway. , 2003, The Journal of clinical endocrinology and metabolism.

[16]  D. Peehl,et al.  Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. , 2003, Endocrinology.

[17]  R. Estabrook,et al.  5α-androstane-3α, 17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α, 17α-diol-20-one as a key intermediate , 2003 .

[18]  G. Shaw,et al.  The marsupial model for male phenotypic development , 2002, Trends in Endocrinology & Metabolism.

[19]  J. Nakae,et al.  Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. , 2001, The Journal of clinical endocrinology and metabolism.

[20]  R. Auchus.  The genetics, pathophysiology, and management of human deficiencies of P450c17. , 2001, Endocrinology and metabolism clinics of North America.

[21]  F. Labrie,et al.  Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1 , 2001 .

[22]  Michael E. Burczynski,et al.  Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .

[23]  M. Forest,et al.  New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. , 1999, The Journal of clinical endocrinology and metabolism.

[24]  T. C. Lee,et al.  Spatial-mode control of vertical-cavity lasers with micromirrors fabricated and replicated in semiconductor materials. , 1999, Applied optics.

[25]  W. Miller,et al.  Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer* , 1998, The Journal of Biological Chemistry.

[26]  D. Peehl,et al.  Expression and Characterization of Recombinant Type 2 3α-Hydroxysteroid Dehydrogenase (HSD) from Human Prostate: Demonstration of Bifunctional 3α/17β-HSD Activity and Cellular Distribution , 1997 .

[27]  D. Russell,et al.  Expression Cloning and Characterization of Oxidative 17β- and 3α-Hydroxysteroid Dehydrogenases from Rat and Human Prostate* , 1997, The Journal of Biological Chemistry.

[28]  W. Miller,et al.  The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. , 1996, The New England journal of medicine.

[29]  F. Labrie,et al.  Molecular Cloning of Human Type 3 3α-Hydroxysteroid Dehydrogenase That Differs from 20α-Hydroxysteroid Dehydrogenase by Seven Amino Acids , 1996 .

[30]  M. J. Bennett,et al.  Mammalian 3α-hydroxysteroid dehydrogenases , 1996, Steroids.

[31]  G. Shaw,et al.  The marsupial male: a role model for sexual development. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[32]  K. O. Elliston,et al.  Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3 , 1994, Nature Genetics.

[33]  D. Russell,et al.  Steroid 5α-Reductase 2 Deficiency , 1993 .

[34]  D. Russell,et al.  Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. , 1993, The Journal of clinical investigation.

[35]  M. Forest,et al.  Congenital adrenal hyperplasia due to point mutations in the type II 3β–hydroxysteroid dehydrogenase gene , 1992, Nature Genetics.

[36]  A. Borut,et al.  Production of testosterone from progesterone by rat testicular microsomes without release of the intermediates 17 alpha-hydroxyprogesterone and androstenedione. , 1987, European journal of biochemistry.

[37]  R. Voutilainen,et al.  Developmental expression of genes for the stereoidogenic enzymes P450scc (20,22-desmolase), P450c17 (17 alpha-hydroxylase/17,20-lyase), and P450c21 (21-hydroxylase) in the human fetus. , 1986, The Journal of clinical endocrinology and metabolism.

[38]  G. Shaw,et al.  The hormonal control of sexual development. , 1981, Novartis Foundation symposium.

[39]  A. Prader,et al.  STEROID 17, 20‐DESMOLASE DEFICIENCY: A NEW CAUSE OF MALE PSEUDOHERMAPHRODITISM , 1972, Clinical endocrinology.

[40]  Russell,et al.  Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. , 1996, The Journal of clinical endocrinology and metabolism.

[41]  J. D. Wilson,et al.  Steroid 5 alpha-reductase: two genes/two enzymes. , 1994, Annual review of biochemistry.

[42]  J. Wilson,et al.  Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. , 1993, The Journal of clinical endocrinology and metabolism.

[43]  M. Grumbach.  Disorders of sex differentiation , 1992 .

[44]  F. S. French,et al.  Molecular basis of androgen insensitivity , 1990 .